Bruno Moulin

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.5K citations · Full text

Genetics and Outcome of Atypical Hemolytic Uremic Syndrome

Véronique Frémeaux‐Bacchi, Fádi Fakhouri, Arnaud Garnier et al. · Clinical Journal of the American Society of Nephrology · 2013 · 698 citations

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

Aude Servais, Laure‐Hélène Noël, Lubka T. Roumenina et al. · Kidney International · 2012 · 555 citations

Glomerular Disease, Vasculitis, Immunology +18

Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing

Éric Thervet, Marie‐Anne Loriot, S. Barbier et al. · Clinical Pharmacology & Therapeutics · 2010 · 362 citations

Post-Transplant Lymphoproliferative Disorders Occurring After Renal Transplantation in Adults: Report of 230 Cases From the French Registry

Sophie Caillard, C. Lelong, Fabienne Pessione et al. · American Journal of Transplantation · 2006 · 264 citations · Full text